RICOH MEG receives FDA 510(k) Clearance

Ricoh has announced that the RICOH MEG Measurement System has received 510(k) clearance from the U.S. FDA. RICOH MEG, Ricoh’s magnetoencephalography system, is a noninvasive way to detect faint signals within the brain. It provides deeper measurement (hippocampus and hypothalamus), clearer signal using coaxial gradiometer sensors and greater patient comfort for better data acquisition.

“Ricoh is committed to helping advance research and treatment for neurological disorders, and MEG is another tool to help healthcare professionals and researchers measure brain activity,” said Scott Abelson, Business Development Director, Medical Imaging, Ricoh USA, Inc.

Ricoh entered the medical device industry when it acquired a portion of a Yokogawa Electric business in 2016.

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Previous Post

Power project working on LED replacements for UV light sources

Next Post

Fanless modular power supply delivers 600W